Nvidia poised to resume h20 sales to china with washington’s blessing

In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan

Issue of the week: Trump’s truce with China ...

It’s there or thereabouts. A technology index by researchers at Harvard, published last month, ranked 25 countries across five sectors: artificial intelligence (AI), semiconductors, biotechnology, spa

Artificial intelligence (AI) is – if you ask any of Silicon Valley’s top CEOs – the biggest opportunity in their company’s history. Few will tell you that it’s also their biggest threat. “For those bi

Intel under pressure: US president Donald Trump backtracked on his criticism of chipmaker Intel’s CEO, Lip-Bu Tan (pictured), hailing Tan as a “success” after meeting him at the White House. Days earl

Tesla posted one its sharpest year-on-year declines in revenue, with boss Elon Musk warning that the trend is set to continue through what is expected to be one of the most challenging periods in the